ADVERTISEMENTS AND TRADING: Roadside Real Estate decreased its stake in Cambridge Sleep.

EARNING AND TRADING: Roadside Real Estate cuts stake in Cambridge Sleep March 20, 2024 at 12:20 p.m. ET from where it came from (Alliance News) - The following is a summary of financial results and trading updates from companies listed on the London Stock Exchange released Wednesday and not reported separately by Alliance News:

Roadside Real Estate PLC

- Of real estate investors in roadside real estate and consumer and life sciences companies, formerly known as Barkby Group PLC

- Sell 952 shares in its Cambridge Sleep Sciences subsidiary for £6 million to CGV Ventures 1 Ltd.

- Indicates a significant increase in the value of the CSS shareholding being left to the company.

- Payment will be made in cash no later than April 25.

- Upon completion of the transaction, Roadside's stake in CSS will decrease from 75% to 65%.

- Roadside initially invested £2.7m in CSS in March 2020.

- The proceeds will be used to repay debt and finance working capital.

- The Company also continues to explore the sale of the business and the demerger of CSS.

- CGV Ventures 1 Ltd. is an American venture capital fund specializing in acquiring minority stakes in innovative healthcare companies.

Mobile Streams PLC

- London mobile content provider

- Completes the placement of shares with the aim of raising £300,539.

- The broker option is expected to attract an additional £100,000, while the subscription will bring in an extra £30,000.

- The funds received will be used to provide additional working capital for expanding operations in Mexico, in line with the plans announced in December.

Beowulf Mining PLC

- a company engaged in the exploration and development of metals and minerals with assets in Northern European countries

- Confirms that the company's management has signed a subscription agreement for shares amounting to £218,000 as part of the capital.

- The subscription period for fundraising will last until March 28.

Zenith Energy Ltd

- An oil and gas company with assets in Africa and Italy

- Provides an update regarding the international arbitration process

- The arbitration court should be convened in April.

- A decision is expected to be made by the end of 2024.

- It is stated that this lawsuit against ETAP amounts to approximately 7.5 million US dollars.

PYX Resources Ltd

- a company engaged in the exploration and development of ore, focused on projects in Indonesia

- Announces the first export shipment of ilmenite after receiving the export license in March.

- The total volume of exported ilmenite amounted to 1,040 tons. Further shipments are expected soon.

Symphony International Holdings Ltd

- an investment company focused on the Asia region

- The net asset value as of December 31 was $0.74 per share, which is 23% lower than the previous year ($0.97).

- Two-thirds of the decline is related to the decrease in the value of Indo Trans Logistics Corp.

It is noted that global markets faced serious challenges in 2023, primarily due to persistent inflation.

Oxford Biomedica PLC

- a gene-cell therapy company from Oxfordshire, England

- There is a consistently high demand for CDMO services in cell and gene therapy across all key viral vectors.

- I signed a contract for the production of lentiviral vectors with a new American biotechnology company.

- I have signed two new programs with clients in the clinical stage for the development of processes and GMP manufacturing standards.

- Concludes a new agreement with a client specializing in heart gene therapy for the transfer of technology, optimization, and production based on adeno-associated virus.

Poolbeg Pharma PLC

- a London-based clinical biopharmaceutical company specializing in the treatment of diseases with high unmet medical need

- I received a notification of approval from the U.S. Patent Office regarding my patent application for immunomodulator II.

- The notification of the permit is "of great importance to Poolbeg, further strengthening our robust intellectual property for the exciting POLB 001 therapy and enhancing its value for potential partners."

Author: Jeremy Cutler, reporter for Alliance News Comments and questions can be sent to [email protected] Copyright 2024 Alliance News Ltd. All rights reserved.